Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication

December 28, 2010 By Bio-Medicine.Org

FRAMINGHAM, Mass. and SYDNEY, Dec. 28, 2010 /PRNewswire/ —
HeartWare International, Inc. (Nasdaq:
HTWR; ASX: HIN) today announced that it has submitted a
Pre-Market Approval (PMA) application to the U.S. Food and Drug
Administration (FDA) for the HeartWare® Ventricular Assist
System as a bridge to heart transplantation for patients with
end-stage heart failure.

The PMA submission includes data from HeartWare’s pivotal
ADVANCE clinical trial, an FDA approved IDE study designed to
evaluate the HeartWare® Ventricular Assist System as a bridge
to heart transplantation for patients with end-stage heart failure.
 Under ADVANCE, 140 patients at 30 hospitals in the U.S.
received the HeartWare investigational device between August 2008
and February 2010.  The final implant in ADVANCE was performed
in February 2010, and the last follow-up evaluation at 180-days was
in August 2010.

Previously announced results for ADVANCE showed that 92% of the
investigational device patients met the per protocol primary
endpoint of the trial, which was defined as alive on the originally
implanted device, transplanted or explanted for recovery at 180
days.  Additionally, ADVANCE demonstrated that 94% of the
investigational device patients enrolled in the study achieved a
survival endpoint at 180 days.

Results for the comparator arm of the study, derived from 499
contemporaneous patients from the Interagency Registry for
Mechanically Assisted Circulatory Support (INTERMACS) demonstrated
90% success of the primary endpoint at 180 days.  Based on
these results for the primary endpoint of the ADVANCE study,
noninferiority of the investigational device was established
[p<0.0001].

About HeartWare InternationalHeartWare International develops
and manufactures miniaturized implantable heart pumps, or
ventricular assist devices, to treat Class IIIB / IV p

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech